Copyright Reports & Markets. All rights reserved.

Global Prescription Weight Loss Medications Market Growth 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Prescription Weight Loss Medications Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Prescription Weight Loss Medications by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Prescription Weight Loss Medications by Country/Region, 2017, 2022 & 2028
  • 2.2 Prescription Weight Loss Medications Segment by Application
    • 2.2.1 Children & Teenagers
    • 2.2.2 Adults
  • 2.3 Prescription Weight Loss Medications Sales by Application
    • 2.3.1 Global Prescription Weight Loss Medications Sales Market Share by Application (2017-2022)
    • 2.3.2 Global Prescription Weight Loss Medications Revenue and Market Share by Application (2017-2022)
    • 2.3.3 Global Prescription Weight Loss Medications Sale Price by Application (2017-2022)
  • 2.4 Prescription Weight Loss Medications Segment by Sales Channel
    • 2.4.1 Online Sales
    • 2.4.2 Offline Sales
  • 2.5 Prescription Weight Loss Medications Sales by Sales Channel
    • 2.5.1 Global Prescription Weight Loss Medications Sale Market Share by Sales Channel (2017-2022)
    • 2.5.2 Global Prescription Weight Loss Medications Revenue and Market Share by Sales Channel (2017-2022)
    • 2.5.3 Global Prescription Weight Loss Medications Sale Price by Sales Channel (2017-2022)

3 Global Prescription Weight Loss Medications by Company

  • 3.1 Global Prescription Weight Loss Medications Breakdown Data by Company
    • 3.1.1 Global Prescription Weight Loss Medications Annual Sales by Company (2020-2022)
    • 3.1.2 Global Prescription Weight Loss Medications Sales Market Share by Company (2020-2022)
  • 3.2 Global Prescription Weight Loss Medications Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Prescription Weight Loss Medications Revenue by Company (2020-2022)
    • 3.2.2 Global Prescription Weight Loss Medications Revenue Market Share by Company (2020-2022)
  • 3.3 Global Prescription Weight Loss Medications Sale Price by Company
  • 3.4 Key Manufacturers Prescription Weight Loss Medications Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Prescription Weight Loss Medications Product Location Distribution
    • 3.4.2 Players Prescription Weight Loss Medications Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Prescription Weight Loss Medications by Geographic Region

  • 4.1 World Historic Prescription Weight Loss Medications Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Prescription Weight Loss Medications Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Prescription Weight Loss Medications Annual Revenue by Geographic Region
  • 4.2 World Historic Prescription Weight Loss Medications Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Prescription Weight Loss Medications Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Prescription Weight Loss Medications Annual Revenue by Country/Region
  • 4.3 Americas Prescription Weight Loss Medications Sales Growth
  • 4.4 APAC Prescription Weight Loss Medications Sales Growth
  • 4.5 Europe Prescription Weight Loss Medications Sales Growth
  • 4.6 Middle East & Africa Prescription Weight Loss Medications Sales Growth

5 Americas

  • 5.1 Americas Prescription Weight Loss Medications Sales by Country
    • 5.1.1 Americas Prescription Weight Loss Medications Sales by Country (2017-2022)
    • 5.1.2 Americas Prescription Weight Loss Medications Revenue by Country (2017-2022)
  • 5.2 Americas Prescription Weight Loss Medications Sales by Application
  • 5.3 Americas Prescription Weight Loss Medications Sales by Sales Channel
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Prescription Weight Loss Medications Sales by Region
    • 6.1.1 APAC Prescription Weight Loss Medications Sales by Region (2017-2022)
    • 6.1.2 APAC Prescription Weight Loss Medications Revenue by Region (2017-2022)
  • 6.2 APAC Prescription Weight Loss Medications Sales by Application
  • 6.3 APAC Prescription Weight Loss Medications Sales by Sales Channel
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Prescription Weight Loss Medications by Country
    • 7.1.1 Europe Prescription Weight Loss Medications Sales by Country (2017-2022)
    • 7.1.2 Europe Prescription Weight Loss Medications Revenue by Country (2017-2022)
  • 7.2 Europe Prescription Weight Loss Medications Sales by Application
  • 7.3 Europe Prescription Weight Loss Medications Sales by Sales Channel
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Prescription Weight Loss Medications by Country
    • 8.1.1 Middle East & Africa Prescription Weight Loss Medications Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Prescription Weight Loss Medications Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Prescription Weight Loss Medications Sales by Application
  • 8.3 Middle East & Africa Prescription Weight Loss Medications Sales by Sales Channel
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Prescription Weight Loss Medications
  • 10.3 Manufacturing Process Analysis of Prescription Weight Loss Medications
  • 10.4 Industry Chain Structure of Prescription Weight Loss Medications

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Prescription Weight Loss Medications Distributors
  • 11.3 Prescription Weight Loss Medications Customer

12 World Forecast Review for Prescription Weight Loss Medications by Geographic Region

  • 12.1 Global Prescription Weight Loss Medications Market Size Forecast by Region
    • 12.1.1 Global Prescription Weight Loss Medications Forecast by Region (2023-2028)
    • 12.1.2 Global Prescription Weight Loss Medications Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Prescription Weight Loss Medications Forecast by Application
  • 12.7 Global Prescription Weight Loss Medications Forecast by Sales Channel

13 Key Players Analysis

  • 13.1 Pfizer
    • 13.1.1 Pfizer Company Information
    • 13.1.2 Pfizer Prescription Weight Loss Medications Product Offered
    • 13.1.3 Pfizer Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Pfizer Main Business Overview
    • 13.1.5 Pfizer Latest Developments
  • 13.2 Bristol-Myers Squibb
    • 13.2.1 Bristol-Myers Squibb Company Information
    • 13.2.2 Bristol-Myers Squibb Prescription Weight Loss Medications Product Offered
    • 13.2.3 Bristol-Myers Squibb Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Bristol-Myers Squibb Main Business Overview
    • 13.2.5 Bristol-Myers Squibb Latest Developments
  • 13.3 Roche
    • 13.3.1 Roche Company Information
    • 13.3.2 Roche Prescription Weight Loss Medications Product Offered
    • 13.3.3 Roche Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Roche Main Business Overview
    • 13.3.5 Roche Latest Developments
  • 13.4 Novo Nordisk
    • 13.4.1 Novo Nordisk Company Information
    • 13.4.2 Novo Nordisk Prescription Weight Loss Medications Product Offered
    • 13.4.3 Novo Nordisk Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Novo Nordisk Main Business Overview
    • 13.4.5 Novo Nordisk Latest Developments
  • 13.5 GlaxoSmithKline
    • 13.5.1 GlaxoSmithKline Company Information
    • 13.5.2 GlaxoSmithKline Prescription Weight Loss Medications Product Offered
    • 13.5.3 GlaxoSmithKline Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 GlaxoSmithKline Main Business Overview
    • 13.5.5 GlaxoSmithKline Latest Developments
  • 13.6 Vivus
    • 13.6.1 Vivus Company Information
    • 13.6.2 Vivus Prescription Weight Loss Medications Product Offered
    • 13.6.3 Vivus Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Vivus Main Business Overview
    • 13.6.5 Vivus Latest Developments
  • 13.7 Currax Pharmaceuticals
    • 13.7.1 Currax Pharmaceuticals Company Information
    • 13.7.2 Currax Pharmaceuticals Prescription Weight Loss Medications Product Offered
    • 13.7.3 Currax Pharmaceuticals Prescription Weight Loss Medications Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Currax Pharmaceuticals Main Business Overview
    • 13.7.5 Currax Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Prescription Weight Loss Medications will have significant change from previous year. According to our (LP Information) latest study, the global Prescription Weight Loss Medications market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Prescription Weight Loss Medications market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Prescription Weight Loss Medications market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Prescription Weight Loss Medications market, reaching US$ million by the year 2028. As for the Europe Prescription Weight Loss Medications landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Prescription Weight Loss Medications players cover Pfizer, Bristol-Myers Squibb, Roche, and Novo Nordisk, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Weight Loss Medications market by product type, application, key manufacturers and key regions and countries.

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Children & Teenagers
Adults

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Online Sales
Offline Sales

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Bristol-Myers Squibb
Roche
Novo Nordisk
GlaxoSmithKline
Vivus
Currax Pharmaceuticals
Buy now